FDA approves GSK RSV vaccine
May 03, 2023 at 13:56 PM EDT
GSK's Arexvy, the first RSV vaccine approved for use in the U.S., gets the green light for older adults.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|